theophylline has been researched along with Apoplexy in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative mean transit time (rMTT) in the infarct core, penumbra, and unaffected tissue were measured using multi-parametric MRI at baseline and 3‑h follow-up in patients treated with theophylline or placebo as an add-on to thrombolytic therapy." | 9.51 | Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis. ( Andersen, G; Fiehler, J; Forkert, ND; Hjort, N; Modrau, B; Nygård Johansen, M; Vorum, H; Winder, A, 2022) |
| "We assessed the effect of single-dose theophylline on intracortical and interhemispheric inhibition in patients with chronic stroke, in a double-blind, placebo-controlled, cross-over study." | 9.22 | The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study. ( Boehme, AK; Lazar, RM; Marshall, RS; Martinez-Hernandez, IE; Schambra, HM; Slane, KJ, 2016) |
| "The objective of this review was to assess the effect of theophylline and its analogues, aminophylline and caffeine, in people with confirmed or presumed acute ischaemic stroke." | 8.82 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, PM, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues (aminophylline and caffeine) in people with confirmed or presumed acute ischaemic stroke." | 8.80 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, FJ; Bath, PM; Mohiuddin, AA, 2000) |
| "The TEA-Stroke trial (The Theophylline in Acute Ischemic Stroke) was an investigator-initiated 2-center, proof-of-concept, phase II clinical study with a randomized, double-blinded, placebo-controlled design." | 7.96 | Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial. ( Andersen, G; Bach, FW; Eskildsen, HW; Hansen, MB; Hjort, N; Johansen, MB; Mikkelsen, IK; Modrau, B; Mouridsen, K; Nielsen, A; Povlsen, JP; Yavarian, Y; Østergaard, L, 2020) |
| "The relative cerebral blood flow (rCBF), relative cerebral blood volume (rCBV), and relative mean transit time (rMTT) in the infarct core, penumbra, and unaffected tissue were measured using multi-parametric MRI at baseline and 3‑h follow-up in patients treated with theophylline or placebo as an add-on to thrombolytic therapy." | 5.51 | Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis. ( Andersen, G; Fiehler, J; Forkert, ND; Hjort, N; Modrau, B; Nygård Johansen, M; Vorum, H; Winder, A, 2022) |
| "We assessed the effect of single-dose theophylline on intracortical and interhemispheric inhibition in patients with chronic stroke, in a double-blind, placebo-controlled, cross-over study." | 5.22 | The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study. ( Boehme, AK; Lazar, RM; Marshall, RS; Martinez-Hernandez, IE; Schambra, HM; Slane, KJ, 2016) |
| "The objective of this review was to assess the effect of theophylline and its analogues, aminophylline and caffeine, in people with confirmed or presumed acute ischaemic stroke." | 4.82 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, PM, 2004) |
| "The objective of this review was to assess the effect of theophylline and its analogues (aminophylline and caffeine) in people with confirmed or presumed acute ischaemic stroke." | 4.80 | Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke. ( Bath, FJ; Bath, PM; Mohiuddin, AA, 2000) |
| "The TEA-Stroke trial (The Theophylline in Acute Ischemic Stroke) was an investigator-initiated 2-center, proof-of-concept, phase II clinical study with a randomized, double-blinded, placebo-controlled design." | 3.96 | Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial. ( Andersen, G; Bach, FW; Eskildsen, HW; Hansen, MB; Hjort, N; Johansen, MB; Mikkelsen, IK; Modrau, B; Mouridsen, K; Nielsen, A; Povlsen, JP; Yavarian, Y; Østergaard, L, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (61.54) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (15.38) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Modrau, B | 2 |
| Andersen, G | 2 |
| Mikkelsen, IK | 1 |
| Nielsen, A | 1 |
| Hansen, MB | 1 |
| Johansen, MB | 1 |
| Eskildsen, HW | 1 |
| Povlsen, JP | 1 |
| Yavarian, Y | 1 |
| Mouridsen, K | 1 |
| Østergaard, L | 1 |
| Bach, FW | 1 |
| Hjort, N | 2 |
| Winder, A | 1 |
| Nygård Johansen, M | 1 |
| Fiehler, J | 1 |
| Vorum, H | 1 |
| Forkert, ND | 1 |
| Schambra, HM | 1 |
| Martinez-Hernandez, IE | 1 |
| Slane, KJ | 1 |
| Boehme, AK | 1 |
| Marshall, RS | 1 |
| Lazar, RM | 1 |
| SACINO, G | 1 |
| ERLEY, E | 1 |
| EICHHORN, O | 1 |
| SLADKI, E | 1 |
| PRUSINSKI, A | 1 |
| DORNAUS, W | 1 |
| PUFFER, E | 1 |
| FREUNDT, KJ | 1 |
| FRUHMANN, H | 1 |
| MUELLER, WK | 1 |
| Bath, PM | 2 |
| Mohiuddin, AA | 1 |
| Bath, FJ | 1 |
2 reviews available for theophylline and Apoplexy
| Article | Year |
|---|---|
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.
Topics: Aminophylline; Brain Ischemia; Caffeine; Humans; Randomized Controlled Trials as Topic; Stroke; Theo | 2004 |
Theophylline, aminophylline, caffeine and analogues for acute ischaemic stroke.
Topics: Aminophylline; Brain Ischemia; Caffeine; Humans; Stroke; Theophylline; Vasodilator Agents | 2000 |
2 trials available for theophylline and Apoplexy
| Article | Year |
|---|---|
Perfusion Changes in Acute Stroke Treated with Theophylline as an Add-on to Thrombolysis : A Randomized Clinical Trial Subgroup Analysis.
Topics: Animals; Brain Ischemia; Cerebrovascular Circulation; Humans; Infarction; Magnetic Resonance Imaging | 2022 |
The neurophysiological effects of single-dose theophylline in patients with chronic stroke: A double-blind, placebo-controlled, randomized cross-over study.
Topics: Adult; Aged; Aged, 80 and over; Blood Pressure; Chronic Disease; Cross-Over Studies; Double-Blind Me | 2016 |
9 other studies available for theophylline and Apoplexy
| Article | Year |
|---|---|
Theophylline as an Add-On to Thrombolytic Therapy in Acute Ischemic Stroke: A Randomized Placebo-Controlled Trial.
Topics: Aged; Aged, 80 and over; Brain Ischemia; Female; Fibrinolytic Agents; Humans; Ischemia; Male; Middle | 2020 |
[Effect of combined theophylline-ethylenediamine, rutin and ascorbic acid in therapy of cerebral apoplexy; early clinico-therapeutic results].
Topics: Aminophylline; Ascorbic Acid; Cerebral Hemorrhage; Ethylenediamines; Flavonoids; Humans; Rutin; Stro | 1955 |
[Experience in the treatment of cerebral apoplexy].
Topics: Cerebral Hemorrhage; Humans; Stroke; Theophylline | 1956 |
[Treatment of stroke with peripherin-Homburg].
Topics: Cerebral Hemorrhage; Humans; Intermediate Filaments; Peripherins; Stroke; Theophylline | 1957 |
[Treatment of apoplexy with a theophylline derivative & ephedrine in the light of recent pathogenetic theories].
Topics: Cerebral Hemorrhage; Ephedrine; Humans; Light; Stroke; Theophylline | 1959 |
[On the therapy of apoplexy].
Topics: Aesculus; Cerebral Hemorrhage; Stroke; Theophylline | 1960 |
[Clinical studies on the therapy of apoplexy].
Topics: Aesculus; Biomedical Research; Fagaceae; Stroke; Theophylline | 1960 |
[ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
Topics: Cerebrovascular Disorders; Geriatrics; Humans; Niacin; Nicotinic Acids; Stroke; Theophylline; Xanthi | 1963 |
[On the treatment of "apoplectic attacks" with apoplectal].
Topics: Aesculus; Fagaceae; Seizures; Stroke; Theophylline | 1960 |